Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens
NCT ID: NCT05211739
Last Updated: 2023-06-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2022-02-15
2022-06-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
NCT06461455
Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses
NCT04980456
Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens
NCT04476784
Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens
NCT04055519
Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT05702541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LID205255 Toric, then Biofinity Toric
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product will be worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Lehfilcon A toric contact lenses
FDA-cleared silicone hydrogel toric contact lenses used as indicated
Comfilcon A toric contact lenses
Commercially available silicone hydrogel toric contact lenses used as indicated
CLEAR CARE
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Biofinity Toric, then LID205255 Toric
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product will be worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Lehfilcon A toric contact lenses
FDA-cleared silicone hydrogel toric contact lenses used as indicated
Comfilcon A toric contact lenses
Commercially available silicone hydrogel toric contact lenses used as indicated
CLEAR CARE
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lehfilcon A toric contact lenses
FDA-cleared silicone hydrogel toric contact lenses used as indicated
Comfilcon A toric contact lenses
Commercially available silicone hydrogel toric contact lenses used as indicated
CLEAR CARE
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected distance visual acuity (as determined by manifest refraction at screening) better than or equal to 20/25 Snellen in each eye.
* Able to wear contact lenses within the range of available sphere \& cylinder power and axes.
Exclusion Criteria
* Monovision and multifocal contact lens wearers.
* Habitual Biofinity Toric/Biofinity Toric XR contact lens wearers in the past 3 months prior to consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, CRD Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sabal Eye Care
Longwood, Florida, United States
Drs. Giedd, P.A.
Maitland, Florida, United States
Vision Health Institute
Orlando, Florida, United States
Kannarr Eye Care LLC
Pittsburg, Kansas, United States
Fischer Laser Eye Center
Willmar, Minnesota, United States
SUNY College of Optometry Clinical Vision Research Center
New York, New York, United States
West Bay Eye Associates
Warwick, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLV201-C002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.